The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90.
Open accessAbstract
The p53 mutant, 143ala, was translated in vitro in either rabbit reticulocyte lysate (RRL) or wheat germ extract (WGE). In RRL, p53-143ala protein of both mutant and wild-type conformation, as detected immunologically with conformation-specific antibodies, was translated. The chaperone protein HSP90, present in RRL, was found to coprecipitate only with the mutated conformation of p53. Geldanamycin, shown previously to bind to HSP90 and destabilize its association with other proteins, decreased the amount of immunologically detectable mutated p53 and increased the amount of detectable wild-type protein, without affecting the total translation of p53. When translated in WGE, known to contain functionally deficient HSP90, p53-143ala produced p53 protein, which was not recognized by a mutated conformation-specific antibody. In contrast, the synthesis of conformationally detectable wild-type p53 in this system was not compromised. Reconstitution of HSP90 function in WGE permitted synthesis of conformationally detectable mutated p53, and this was abrogated by geldanamycin. Finally, when p53-143ala was stably tansfected into yeast engineered to be defective for HSP90 function, conformational recognition of mutated p53 was impaired. When stable transfectants of p53-143ala were prepared in yeast expressing wild-type HSP90, conformational recognition of mutated p53 was antagonized by macbecin I, a geldanamycin analog also known to bind HSP90. Taken together, these data demonstrate a role for HSP90 in the achievement and/or stabilization of the mutated conformation of p53-143ala. Furthermore, we show that the mutated conformation of p53 can be pharmacologically antagonized by drugs targeting HSP90.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Self-citationOncogenic forms of p53 inhibit p53-regulated gene expression
Kern, S., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940
Gain of function mutations in p53
Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A. K., Moore, M., Finlay, C., & Levine, A. J. (1993) · Nature Genetics · doi:10.1038/ng0593-42 · Cited by 894
Reduced levels of hsp90 compromise steroid receptor action in vivo
Picard, D., Khursheed, B., Garabedian, M. J., Fortin, M. G., Lindquist, S., & Yamamoto, K. R. (1990) · Nature · doi:10.1038/348166a0 · Cited by 787
Gannon, J. V., Greaves, R., Iggo, R., & Lane, D. P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08279.x · Cited by 688
Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.
Bártek, J., Iggo, R. D., Gannon, J., & Lane, D. P. (1990) · PubMed · Cited by 658
Milner, J., & Medcalf, E. A. (1991) · Cell · doi:10.1016/0092-8674(91)90384-b · Cited by 612
Heat-shock protein hsp90 governs the activity of pp60v-src kinase.
Xu, Y., & Lindquist, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7074 · Cited by 416
Sequence-specific transcriptional activation is essential for growth suppression by p53.
Pietenpol, J. A., Tokino, T., Thiagalingam, S., el-Deiry, W. S., Kinzler, K. W., & Vogelstein, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.1998 · Cited by 406
Donehower, L. A., & Bradley, A. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90004-v · Cited by 333
Specific interaction between the p53 cellular tumour antigen and major heat shock proteins
Pinhasi-Kimhi, O., Michalovitz, D., Ben-Zeev, A., & Oren, M. (1986) · Nature · doi:10.1038/320182a0 · Cited by 329
Progesterone Receptor Structure and Function Altered by Geldanamycin, an hsp90-Binding Agent
Smith, D. F., Whitesell, L., Nair, S. C., Chen, S., Prapapanich, V., & Rimerman, R. A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6804 · Cited by 289
Binding of p23 and hsp90 during assembly with the progesterone receptor.
Johnson, J. L., & Toft, D. O. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.6.8592513 · Cited by 233
Johnson, J. L., & Toft, D. O. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31487-4 · Cited by 229
Geldanamycin selectively destabilizes and conformationally alters mutated p53.
Blagosklonny, M. V., Toretsky, J. A., & Neckers, L. (1995) · PubMed · Cited by 202
Self-citationIsolation of Hsp90 mutants by screening for decreased steroid receptor function.
Bohen, S. P., & Yamamoto, K. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11424 · Cited by 195
Self-citationHw, S., Chumakov, P. M., Wj, W., & Jenkins, J. R. (1987) · PubMed · Cited by 163
The 90-kDa heat shock protein is essential for Ah receptor signaling in a yeast expression system.
Carver, L. A., Jackiw, V, & Bradfield, C. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43782-9 · Cited by 159
Shaknovich, R., Shue, G., & Kohtz, D. S. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5059 · Cited by 153
Antonsson, C., Whitelaw, M. L., McGuire, J., Gustafsson, J.-Α., & Poellinger, L. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.756 · Cited by 145
Heat shock protein hsp90 regulates dioxin receptor function in vivo.
Whitelaw, M. L., McGuire, J., Picard, D., Gustafsson, J.-Α., & Poellinger, L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4437 · Cited by 140
A temperature‐sensitive mutant of human p53.
Zhang, W., Guo, X. Y., Hu, G., Liu, W. B., Shay, J. W., & Deisseroth, A. B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06543.x · Cited by 139
Hainaut, P. L., & Milner, J. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05434.x · Cited by 138
Hsiao, M., Low, J., Dorn, E., Ku, D., Pattengale, P. K., Yeargin, J., & Haas, M. (1994) · PubMed Central · Cited by 135
Hutchison, K. A., Stancato, L. F., Owens-Grillo, J. K., Johnson, J. L., Krishna, P., Toft, D. O., & Pratt, W. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18841 · Cited by 121
Milner, J., & Watson, J. V. (1990) · PubMed · Cited by 108
Mimnaugh, E. G., Worland, P. J., Whitesell, L. J., & Neckers, L. Μ. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28654 · Cited by 102
Self-citationFlexibility: the key to p53 function?
Milner, J. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)88954-9 · Cited by 88
Shue, G.-H., & Kohtz, D. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42001-1 · Cited by 88
Zhang, W., Hu, G., Estey, E. H., Hester, J. P., & Deisseroth, A. B. (1992) · PubMed · Cited by 87
A role for Hsp90 in retinoid receptor signal transduction.
Holley, S., & Yamamoto, K. R. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.12.1833 · Cited by 83
Milner, J., Cook, A., & Sheldon, M. J. (1987) · PubMed · Cited by 78
Mutational analysis of hsp90 binding to the progesterone receptor.
Sullivan, W. P., & Toft, D. O. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80738-8 · Cited by 63
Milner, J. (1991) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1991.0100 · Cited by 62
Hsp90 Mutants Disrupt Glucocorticoid Receptor Ligand Binding and Destabilize Aporeceptor Complexes
Bohen, S. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29433 · Cited by 49
Self-citationTemperature sensitivity for conformation is an intrinsic property of wild-type p53
Hainaut, P. L., Butcher, S., & Milner, J. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.48 · Cited by 49
Milner, J. (1994) · PubMed · Cited by 39
Shaknovich, R., Shue, G., & Kohtz, D. S. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5059-5068.1992 · Cited by 27
Cited by
HSP90 and the chaperoning of cancer
Whitesell, L., & Lindquist, S. L. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1716 · Cited by 2,502
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791
Schopf, F. H., Biebl, M. M., & Buchner, J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.20 · Cited by 1,540
Pratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,483
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
Ciocca, D. R., & Calderwood, S. K. (2005) · Cell Stress & Chaperones · doi:10.1379/csc-99r.1 · Cited by 1,404
Metadata
- Authors
- Blagosklonny, M. V., Toretsky, J., Bohen, S., & Neckers, L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-08-06
- Volume
- 93
- Issue
- 16
- Pages
- 8379-8383
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2040196552
- Cited by
- 314
- References
- 40
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.